Preclinical Evaluation of Oral Urolithin-A for the Treatment of Acute Campylobacteriosis in <i>Campylobacter jejuni</i> Infected Microbiota-Depleted IL-10<sup>-/-</sup> Mice

Preclinical Evaluation of Oral Urolithin-A for the Treatment of Acute Campylobacteriosis in <i>Campylobacter jejuni</i> Infected Microbiota-Depleted IL-10<sup>-/-</sup> Mice

Human campylobacteriosis represents an infectious enteritis syndrome caused by <i>Campylobacter</i> species, mostly <i>Campylobacter jejuni</i>. Given that <i>C. jejuni</i> infections are rising worldwide and antibiotic treatment is usually not indicated, novel tr...

Full description

Bibliographic Details
Main Authors: Soraya Mousavi, Dennis Weschka, Stefan Bereswill, Markus M. Heimesaat
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Pathogens
Subjects:
Urolithin-A
enteropathogenic infection
<i>Campylobacter jejuni</i>
immune-modulatory effects
secondary abiotic IL-10<sup>-/-</sup> mice
campylobacteriosis model
Online Access:https://www.mdpi.com/2076-0817/10/1/7

Internet

https://www.mdpi.com/2076-0817/10/1/7

Similar Items